Additionally, in an angiotensin II-dependent hypertensive rat model, CB1R inhibition improved cardiac function and remodeling after myocardial infarction and metabolic syndrome, improving blood-pressure regulation and the metabolic profile [126,127,128]. This evidence concerns the gene CNR1 and metabolic syndrome.